Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)

CNY 3.21

(-0.93%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 5.47 Billion 5.85 Billion 5.43 Billion 6.54 Billion 6.14 Billion 6.04 Billion
Total Current Assets 1.73 Billion 2.09 Billion 1.94 Billion 2.67 Billion 2.75 Billion 3.05 Billion
Cash And Short Term Investments 744.46 Million 878.78 Million 761.56 Million 888.12 Million 1.31 Billion 1.45 Billion
Cash and Cash Equivalents 744.34 Million 764.66 Million 761.56 Million 882.82 Million 1.31 Billion 1.45 Billion
Short Term Investments 118.6 Thousand 114.11 Million -105.16 Million 5.3 Million -94.1 Million -42.12 Million
Net Receivables 281.83 Million 316.62 Million 382.86 Million 560.79 Million 484.34 Million 660.78 Million
Inventory 691.6 Million 821.34 Million 714.77 Million 756.05 Million 831.09 Million 893.48 Million
Other Current Assets 13.1 Million 74.44 Million 87.16 Million 470.25 Million 118.59 Million 47.36 Million
Total Non-Current Assets 3.74 Billion 3.76 Billion 3.48 Billion 3.87 Billion 3.38 Billion 2.98 Billion
Net PPE 2.94 Billion 2.85 Billion 2.6 Billion 2.95 Billion 2.71 Billion 2.58 Billion
Good Will And Intangible Assets 380.03 Million 416.14 Million 441.45 Million 547.05 Million 404.38 Million 276.49 Million
Good Will 2 Million 10 Million 10 Million 21.82 Million 21.82 Million 21.82 Million
Intangible Assets 378.03 Million 406.13 Million 431.44 Million 525.22 Million 382.56 Million 254.66 Million
Long-Term Investments 251.51 Million 74.85 Million 301.32 Million 150.65 Million 202.19 Million 68.03 Million
Tax Assets 152.13 Million 168.7 Million 118.33 Million 58.97 Million 51.6 Million 15.54 Million
Other Non Current Assets 23.66 Million 248.2 Million 20.08 Million 157.23 Million 17.93 Million 43.9 Million
Other Assets - - - - - -
Total Liabilities 650.66 Million 804.56 Million 558.27 Million 753.21 Million 350.71 Million 409.39 Million
Total Current Liabilities 603.3 Million 725.43 Million 498.92 Million 691.5 Million 255.59 Million 279.14 Million
Account Payables 122.29 Million 198.7 Million 137.87 Million 137.93 Million 117.43 Million 93.37 Million
Tax Payables 991.53 Thousand 3.69 Million 4.8 Million 11.64 Million 23.49 Million 24.46 Million
Short Term Debt 361.44 Million 400.75 Million 249.88 Million 463 Million -57.86 Million 22.8 Million
Deferred Revenue 47.01 Million 119.75 Million 106.72 Million 86.6 Million 57.86 Million 94.83 Million
Other Current Liabilities 72.54 Million 6.22 Million 4.44 Million 3.97 Million 138.16 Million 68.12 Million
Total Non Current Liabilities 47.36 Million 79.13 Million 59.35 Million 61.71 Million 95.12 Million 130.25 Million
Long-Term Debt 1.16 Million 2.57 Million 2.15 Million 1.53 Million 1.00 -
Deferred Revenue Non Current 18.38 Million 23.14 Million 27.91 Million 34.01 Million 34.9 Million 40.8 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -18.38 Million 1.00 1.00 -1.53 Million 37.22 Million 66.1 Million
Other Liabilities -0.00 1.00 - 1.00 1.00 1.00
Total Equity 4.81 Billion 5.05 Billion 4.87 Billion 5.79 Billion 5.79 Billion 5.63 Billion
Stock Holders Equity 4.83 Billion 5.05 Billion 4.85 Billion 5.76 Billion 5.75 Billion 5.59 Billion
Common Stock 2.06 Billion 2.06 Billion 2.06 Billion 2.06 Billion 2.06 Billion 2.06 Billion
Retained Earnings 1.54 Billion 1.8 Billion 1.76 Billion 2.71 Billion 2.55 Billion 2.41 Billion
Accumulated other comprehensive income 221.5 Million 193.32 Million 47.99 Million 98.05 Million 203.21 Million 177.89 Million
Common Stock Equity 4.83 Billion 5.05 Billion 4.85 Billion 5.76 Billion 5.75 Billion 5.59 Billion
Capital Lease Obligation 1.16 Million 2.57 Million 2.15 Million 1.53 Million - -
Total Investments 251.63 Million 188.96 Million 196.15 Million 155.95 Million 108.08 Million 25.9 Million
Total Debt 362.61 Million 403.32 Million 252.03 Million 463 Million - 22.8 Million
Net Debt -381.73 Million -361.34 Million -509.52 Million -419.82 Million -1.31 Billion -1.43 Billion

Balance Sheet Charts